Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine and Cytarabine for MRD in AML
NCT00863434Phase 2Terminated
- Sponsor
- University of Washington
- Start
- Feb 2009
- Primary completion
- Feb 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), sponsored by University of Washington. Started Feb 2009; status: terminated.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00863434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00863434.